Allen Brinker - Concepedia

Author

Allen Brinker

Center for Drug Evaluation and Research

Also Known As

A Brinker, A. Brinker, ALLEN BRINKER, Allen Brinker, Allen D Brinker, Allen D. Brinker

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Center for Drug Evaluation and Research United States Food and Drug Administration Food and Drug Administration

About

Allen Brinker is an author at Center for Drug Evaluation and Research specializing in medicine, pharmacotherapy, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	771
2	Public Health	1	1	20
3	Allergy	1	1	11
4	Anatomy	1	1	32
5	Biostatistics	1	1	20

Allen Brinker

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Retrospective analysis of mortalities associated with medication errors Jerry L. Phillips, Sammie Beam, Allen Brinker, American Journal of Health-System Pharmacy Drug SafetyAdverse EventPharmacoepidemiologyPatient SafetyRetrospective Analysis	2001	352
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients Namita Kothary, Ida-Lina Diak, Allen Brinker, Journal of the American Academy of Dermatology InflammationAutoimmune DiseaseMedicinePathologyClinical Dermatology	2011	133
Telithromycin‐associated hepatotoxicity Allen Brinker, Ronald T. Wassel, Jenna Lyndly, Hepatology	2008	115
Hypertension: A new safety risk for patients treated with erenumab Suprat Saely, David Croteau, Laura Jawidzik, Headache The Journal of Head and Face Pain	2021	95
Comparison of Reporting of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Selective COX-2 Inhibitors Lois La Grenade, Lauren Lee, Joyce Weaver, Drug Safety Toxic Epidermal NecrolysisMedicineStevens-johnson SyndromePathologySelective Cox-2 Inhibitors	2005	84
Brief Communication: Characteristics of Spontaneous Cases of Tuberculosis Associated with Infliximab Angela Raval, Gita Akhavan-Toyserkani, Allen Brinker, Annals of Internal Medicine	2007	83
Trends in Adherence to a Revised Risk Management Program Designed to Decrease or Eliminate Isotretinoin-Exposed Pregnancies Allen Brinker, Cynthia Kornegay, Parivash Nourjah Archives of Dermatology	2005	67
Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors Christopher G. Rowan, Allen Brinker, Parivash Nourjah, Pharmacoepidemiology and Drug Safety	2009	55
Spontaneous reports of thrombocytopenia in association with quinine: Clinical attributes and timing related to regulatory action Allen Brinker, Julie Beitz American Journal of Hematology MalariaPathologyCase SeriesPharmacotherapyProfound Thrombocytopenia	2002	36
Profiling Cumulative Proportional Reporting Ratios of Drug-Induced Liver Injury in the FDA Adverse Event Reporting System (FAERS) Database Allen Brinker, Jenna Lyndly, Joseph M. Tonning, Drug Safety Drug SafetyHepatologyAdverse EventLiver PhysiologyPatient Safety	2013	36

Page 1